supply of sr phcode-153056-coronary drug eluting stents.sr phcode-153056-coronary drug eluting stents.,sr phcode-153056-coronary drug eluting stents with (1) cobalt chromium alloy and w ith coating of polymer carrier for active drug everolimus. (2) crossing profile less than or equa l to 0.0425 inch and mid marker stent placement. (3) stent diameter should be from 2.0 mm to 4 mm and length of the stent from 8 mm to 38 mm. (4) the strut thickness should be 81 micron. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent shou ld be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent sho uld be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the l ong term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in -situ thrombosis (ist) should be documented / published in peer reviewed scientific journals.(10) th e documents pertaining to the efficacy and safety of the stent should be enclosed in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major governm ent institute. [ warranty period: 30 months after the date of delivery ] ]